Anixa Biosciences (ANIX) Net Income (2010 - 2026)

Anixa Biosciences (ANIX) has reported Net Income for 17 consecutive years, with -$2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income rose 9.85% year-over-year to -$2.5 million; the trailing twelve-month figure through Apr 2026 stood at -$10.4 million (up 15.53% YoY), and the FY2025 full-year result was -$11.0 million, up 13.15% from the prior year.
• Net Income grew to -$2.5 million in Q2 2026 per ANIX's latest filing, from -$2.7 million in the prior quarter.
• Across five years, Net Income topped out at -$2.3 million in Q3 2025 and bottomed at -$3.9 million in Q1 2022.
• Historically, Net Income has averaged -$2.9 million across 5 years, with a median of -$2.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Income tumbled 73.79% in 2022, then soared 39.31% in 2023.
• Over 5 years, Net Income stood at -$3.5 million in 2022, then increased by 22.9% to -$2.7 million in 2023, then decreased by 7.06% to -$2.9 million in 2024, then increased by 6.56% to -$2.7 million in 2025, then increased by 6.83% to -$2.5 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered -$2.5 million, -$2.7 million, and -$2.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.